Position in MRNA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$278,019
-$460,496 QoQ
Shares Held
3,970
-46.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#450
of 772 holders
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STEVENS CAPITAL MANAGEMENT LP holds $642,789 across 2 Biotechnology names. MRNA ranks #2 (43.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
585 | $364,770 | |
| 2 | MRNA |
Moderna, Inc.
This page
|
3,970 | $278,019 |
All Filings in MRNA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $278,019 | 3,970 | Shares | Sole | 2026-08-11 | |
| 2023-12-31 | $738,515 | 7,426 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $3,727,322 | 36,086 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,519,114 | 12,503 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,124,309 | 39,877 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,823,681 | 10,153 | Shares | Sole | 2023-02-06 | |
| 2022-06-30 | $7,735,898 | 54,154 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,914,953 | 22,727 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,730,550 | 22,563 | Shares | Sole | 2022-01-28 | |
| No filing history on record for this holder in this stock. | ||||||